Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse-Reference-Cited by-同舟云学术

Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse

Published:2005-02-10 Issue:4 Volume:19 Page:507-512
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Marin D,Kaeda J,Szydlo R,Saunders S,Fleming A,Howard J,Andreasson C,Bua M,Olavarria E,Rahemtulla A,Dazzi F,Kanfer E,Goldman J M,Apperley J F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2403664.pdf

Reference17 articles.

1. Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002; 346: 645–652.

2. Hughes TP, Kaeda J, Branford S, Rudzki Z, Hochhaus A, Hensley ML et al. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N Engl J Med 2003; 349: 1423–1432.

3. Marin D, Marktel S, Szydlo R, Klein JP, Bua M, Foot N et al. Survival of patients with chronic-phase chronic myeloid leukaemia on imatinib after failure on interferon alfa. Lancet 2003; 362: 617–619.

4. Kantarjian HM, Dixon D, Keating MJ, Talpaz M, Walters RS, McCredie KB et al. Characteristics of accelerated disease in chronic myelogenous leukemia. Cancer 1988; 61: 1441–1446.

5. Sokal JE, Cox EB, Baccarani M, Tura S, Gomez GA, Robertson JE et al. Prognostic discrimination in ‘good-risk’ chronic granulocytic leukemia. Blood 1984; 63: 789–799.

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond IC₅₀- A computational dynamic model of drug resistance in enzyme inhibition treatment;2024-03-26

2. Molecular Pathogenesis and Treatment Strategies of Chronic Myeloid Leukemia (CML);Sudan Journal of Medical Sciences;2023-12-29

3. Promyelocytic Blast Crisis of Chronic Myeloid Leukemia in a Patient Undergoing Therapy with a Tyrosine Kinase Inhibitor;Cureus;2020-03-09

4. Translating insights into tumor evolution to clinical practice: promises and challenges;Genome Medicine;2019-03-29

5. Development and evaluation of armored RNA ‐based standards for quantification of BCR ‐ ABL 1 p210/p190 fusion gene transcripts;Journal of Clinical Laboratory Analysis;2018-06-29